News

Eppendorf significantly expands capacities for the production of consumables

15/05/20

> Construction of two additional production halls at the Oldenburg site

> Strong capacity expansion by 30 percent from 2021

Free Webinar on Improving qPCR Reliability with Smart Plastics

13/05/20

This Eppendorf webinar together with Michael Pfaffl, one of the qPCR pioneers, will show you how to improve qPCR reliability and reproducibility using smart plastics.

Free Webinar on Nucleic Acid Purification

21/04/20

Nucleic Acid Purification – Understanding the details, tackle the routines!

Eppendorf AG posts a strong fiscal year 2019

20/04/20

> Revenue rises to €803.9 million (prior year: €729.2 million)

> At 10.2%, revenue growth exceeds industry average

> Operating profit reaches €144.2 million with an EBIT margin of 17.9%

> All sales regions and product groups are developing positively

> R&D investments increase by 11.2% to €50.3 million

 

“Woman of the Week“ – Podcast with Eva van Pelt, Co-CEO & Chief Commercial Officer of Eppendorf AG

03/04/20

In the podcast "Woman of the Week" from Bayerischer Rundfunk, Eva van Pelt, Co-CEO & Chief Commercial Officer, spoke with Vanessa Schneider.

 

Eva talks about the current effects of the Coronavirus and Eppendorf's contribution, but also about her own personal career and formative moments in her professional life. She also gives insights on what helped her in her career. Her personal business tips are not only interesting for women.

Eppendorf Award 2020 Goes to Randall Platt

03/04/20

The independent Eppendorf Award Jury chaired by Prof. Reinhard Jahn selected Prof. Dr. Randall J. Platt, Assistant Professor of Biological Engineering, ETH Zurich, Switzerland, as the 2020 winner of the Eppendorf Award for Young European Investigators.

Eppendorf acquires centrifuge business of Koki Holdings Co., Ltd.

19/03/20

Hamburg/Tokyo, March 19, 2020 – Eppendorf AG and Koki Holdings Co., Ltd., have reached an agreement that Eppendorf will acquire Koki’s centrifuge business, including the premium himac brand. A corresponding agreement was signed by both companies in Tokyo. The acquisition marks a targeted step by Hamburg-based Eppendorf AG to expand its centrifuge business and solidifies its strong market position as one of the world’s leading makers of high-end centrifuges for the pharma and life science industries as well as academic and commercial research.

Free Webinar on Cell-Based Assays

28/02/20

From Cell Seeding to Analysis - Getting the Best Out of Your Cell-based Assay

Relaunch of the Eppendorf app

14/02/20

Discover the Digital World of Eppendorf

Call for Entries!

22/01/20

Eppendorf & Science Prize for Neurobiology 2020